Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Mycology Immunoassays Testing Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Mycology Immunoassays Testing Industry
  • 1.7 COVID-19 Impact: Mycology Immunoassays Testing Market Trends

    • 2 Global Mycology Immunoassays Testing Quarterly Market Size Analysis

    • 2.1 Mycology Immunoassays Testing Business Impact Assessment - COVID-19
      • 2.1.1 Global Mycology Immunoassays Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Mycology Immunoassays Testing Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Mycology Immunoassays Testing Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Mycology Immunoassays Testing Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Mycology Immunoassays Testing Market
    • 3.4 Key Players Mycology Immunoassays Testing Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Mycology Immunoassays Testing Segments, By Type

    • 4.1 Introduction
      • 1.4.1 ELISA
      • 1.4.2 Rapid Tests
      • 1.4.3 ELISPOT
      • 1.4.4 Polymerase Chain Reaction (PCR)
    • 4.2 By Type, Global Mycology Immunoassays Testing Market Size, 2019-2021

    5 Impact of Covid-19 on Mycology Immunoassays Testing Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospitals
      • 5.5.2 Blood Banks
      • 5.5.3 Others
    • 5.2 By Application, Global Mycology Immunoassays Testing Market Size, 2019-2021
      • 5.2.1 By Application, Global Mycology Immunoassays Testing Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Roche
      • 7.1.1 Roche Business Overview
      • 7.1.2 Roche Mycology Immunoassays Testing Quarterly Revenue, 2020
      • 7.1.3 Roche Mycology Immunoassays Testing Product Introduction
      • 7.1.4 Roche Response to COVID-19 and Related Developments
    • 7.2 Abbott
      • 7.2.1 Abbott Business Overview
      • 7.2.2 Abbott Mycology Immunoassays Testing Quarterly Revenue, 2020
      • 7.2.3 Abbott Mycology Immunoassays Testing Product Introduction
      • 7.2.4 Abbott Response to COVID-19 and Related Developments
    • 7.3 Siemens
      • 7.3.1 Siemens Business Overview
      • 7.3.2 Siemens Mycology Immunoassays Testing Quarterly Revenue, 2020
      • 7.3.3 Siemens Mycology Immunoassays Testing Product Introduction
      • 7.3.4 Siemens Response to COVID-19 and Related Developments
    • 7.4 Beckman Coulter
      • 7.4.1 Beckman Coulter Business Overview
      • 7.4.2 Beckman Coulter Mycology Immunoassays Testing Quarterly Revenue, 2020
      • 7.4.3 Beckman Coulter Mycology Immunoassays Testing Product Introduction
      • 7.4.4 Beckman Coulter Response to COVID-19 and Related Developments
    • 7.5 Ortho-Clinical Diagnostics
      • 7.5.1 Ortho-Clinical Diagnostics Business Overview
      • 7.5.2 Ortho-Clinical Diagnostics Mycology Immunoassays Testing Quarterly Revenue, 2020
      • 7.5.3 Ortho-Clinical Diagnostics Mycology Immunoassays Testing Product Introduction
      • 7.5.4 Ortho-Clinical Diagnostics Response to COVID-19 and Related Developments
    • 7.6 bioMérieux
      • 7.6.1 bioMérieux Business Overview
      • 7.6.2 bioMérieux Mycology Immunoassays Testing Quarterly Revenue, 2020
      • 7.6.3 bioMérieux Mycology Immunoassays Testing Product Introduction
      • 7.6.4 bioMérieux Response to COVID-19 and Related Developments
    • 7.7 ELITechGroup
      • 7.7.1 ELITechGroup Business Overview
      • 7.7.2 ELITechGroup Mycology Immunoassays Testing Quarterly Revenue, 2020
      • 7.7.3 ELITechGroup Mycology Immunoassays Testing Product Introduction
      • 7.7.4 ELITechGroup Response to COVID-19 and Related Developments
    • 7.8 MiraVista Diagnostics
      • 7.8.1 MiraVista Diagnostics Business Overview
      • 7.8.2 MiraVista Diagnostics Mycology Immunoassays Testing Quarterly Revenue, 2020
      • 7.8.3 MiraVista Diagnostics Mycology Immunoassays Testing Product Introduction
      • 7.8.4 MiraVista Diagnostics Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Mycology Immunoassays Testing, including the following market information:
      Global Mycology Immunoassays Testing Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Mycology Immunoassays Testing Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Mycology Immunoassays Testing Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Mycology Immunoassays Testing Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Roche, Abbott, Siemens, Beckman Coulter, Ortho-Clinical Diagnostics, bioMérieux, ELITechGroup, MiraVista Diagnostics, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      ELISA
      Rapid Tests
      ELISPOT
      Polymerase Chain Reaction (PCR)

      Based on the Application:
      Hospitals
      Blood Banks
      Others

      Buy now